vivo Science is a GLP/GMP certified service company for the pharmaceutical industry (CRO which offers preclinical testing.From the testing of immunotoxicity (ICH S8) and immunogenicity (ICH S6) of new drug candidates, over repeated dose toxicity studies (OECD 407, 408) and biocompatibility test (ISO 10993) to safety and potency tests for vaccines, vivo Science provides a wide range of in-vivo tests in rodents. vivo Science provides GLP/GMP compliant, validated study protocols and can also assist in setting up a customized test program.
By merging with the international Texcell Group with subsidiaries in Europe, Asia and North America, vivo Science, the German subsidiary of Texcell, has expanded its portfolio and now offers preclinical testing of biologics, pharmaceuticals, medical devices, vaccines and chemicals as well as in GMP cell banking and viral safety.
Since March 2019, vivo Science has been working together with komIT and other partners from industry and university to advance the development of new therapies for diabetes. The goal of the cooperation is the establishment of a sustainable infrastructure that bundles expertise from management, medical chemistry, preclinical, analytics, toxicology and physiology to clinical trials and provides an open platform for NRW, Germany and Europe.